While we do not currently charge cancellation or no-show fees, we appreciate your consideration in letting us know as early as possible
Maiti A, MBBS, DiNardo CD, MD, MSCE, Rausch CR, PharmD, Pemmaraju N, MD, Garcia-Manero G, MD, Ohanian M, DO, Daver N, MD, Issa GC, MD, Borthakur G, MD, Ravandi F, MBBS, Alvarado Y, MD, Kadia TM, MD, Short NJ, MD, Jabbour EJ, MD, Montalban-Bravo G, MD, Jain N, MD, Kornblau SM, MD, Masarova L, MD, Wierda WG, Sasaki K, MD, PhD, Takahashi K, MD, PhD, Yilmaz M, MD, Burger JA, MD, PhD, Estrov ZE, MD, Verstovsek S, MD, PhD, Andreeff M , MD, PhD, Bose P, MD, Ferrajoli A, MD, Thompson PA, Montalbano K, Vaughan K, RN, Bivins CA, RN, Pierce SA, BSN, BA, Qiao W, PhD, Ning J, Welch J, PhD MD, Kantarjian H, MD, Konopleva M, MD, PhD
Neuroimaging of mitochondrial cytopathies
FIGURE 6 4 Discussion Oncolytic CVA21 drug substance was manufactured for early clinical supply using poorly scalable technologies including MRC-5 static culture in cell stacks and purification by ultracentrifugation